Cardiac Biomarker Diagnostic Kits Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
The global cardiac biomarker diagnostic kits market is poised to reach USD 4.5 billion by 2026 end and achieve a CAGR of over 7% from the forecast period 2019-2026.
Increasing focus
towards research and development activities coupled with the launch of high
sensitive cardiac biomarker kits remain the major factors increasing the
cardiac biomarker diagnostic kits market size. The increasing cases of cardiovascular
diseases are accelerating the growth of the market. According to the World
Health Organization, cardiovascular diseases remain a major cause of death from
a disease. Over 17.9 million people die each year from CVDs, an estimated 31%
of all deaths worldwide. Increasing geriatric population is also contributing
towards growth of the market.
The market is
bifurcated into by type, by product, by disease, by type of testing and by
region. On the basis of product, troponin I and T segment is expected to
dominate the growth of the market. The troponin I and T segment offer high
sensitivity, rapid prediction of morality or outcomes and longer elevation
time. All these aforementioned factors have boosted the demand for troponin I
and T segment, thus increasing the cardiac biomarker diagnostic kits market
share.
In terms of product,
the reagents and kits segment is expected to increase the cardiac biomarker
diagnostic kits market size. The rise in number of cardiac biomarker tests
performed because of increasing cases of cardiovascular diseases has led to
more demand for reagents and kits. The launch of new, reliable and faster has
resulted in more demand for reagents and kits, thus propelling the global
cardiac biomarker diagnostic kits market growth.
Based on testing, the
point of care testing segment is expected to control the growth of the market.
Point-of-care testing offers advantages like improved patient satisfaction and
improved emergency department efficiency. It also provides simple sample
collection and technological and reduction in length of stay. Owing to these
factors there has been a spike in demand for point-of-care testing, thus
expanding the cardiac biomarker diagnostic kits market share.
In terms of disease,
myocardial infarction segment is expected to control the growth of the market.
The increasing number of patients needed for investigation for the diagnosis of
acute myocardial infarction remains the major factor boosting the growth of the
market.
On the basis of
region, North America dictates the growth of the market. Factors such a rise in
public-private initiatives to spread awareness related to cardiac diseases
coupled with rising cases of cardiovascular diseases are bolstering the market
in the region. Technological advancements and increasing geriatric population
are also increasing the cardiac biomarker diagnostic kits size in the region.
Asia-Pacific is
considered a lucrative region owing to the rising incidence and prevalence of
cardiovascular diseases in the region. Emerging economies like India and China
are becoming lucrative destinations for manufacturers. China has one of the
highest deaths related to cardiovascular disease. According to figures released
by American Heart Association, every one in five adults in China has cardiovascular
disease. Technological advancements among cardiologists are escalating the
market in the region.
Prominent
players of the market are bioMerieux SA, Guangzhou Wondfo Biotech Co., Ltd,
Danaher Corporation, Siemens AG, Abbott Laboratories, Alere, Inc., LSI Medience
Corporation, Randox laboratories, and Ortho Clinical Diagnostics.
Request a
Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3459&page=requestsample
Competitive
Landscape:
- Abbott in 2017 acquired
Alere. The acquisition helped in bolstering the company's portfolio
Global
Cardiac Biomarker Diagnostic Kits Market Segmentation
By
Type
- Troponin I and T
- CK-MB
- Bnp Or Nt-Probnp
- Myoglobin
- Hscrp
- Other Biomarkers
By
Product
- Reagents and Kits
- Instruments
- Chemiluminescence
- Immunofluorescence
- Elisa
- Immunochromatography
By
Disease
- Myocardial Infarction
- Congestive Heart
Failure
By
Type of Testing
- Laboratory
Testing
- Point-Of-Care
Testing
By
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Rest of the World
Purchase
a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3459&page=askfordiscount
FutureWise Key Takeaways:
- Growth Prospects
- SWOT Analysis
- Key Trends
- Key data-points affecting market growth
Objectives
of the Study:
- To provide with an exhaustive analysis on the
global cardiac biomarker diagnostic kits market by type, by product, by
disease, by type of testing and by region
- To cater comprehensive information on
factors impacting market growth (drivers, restraints, industry-specific
restraints and opportunities)
- To forecast and evaluate micro-markets and the
overall market
- To predict the market size, in key regions (along
with countries)— North America, Europe, Asia Pacific, Latin America and
the rest of the world
- To record, evaluate and analyse competitive
landscape mapping- technological advancements, product launches,
expansions and mergers
We
specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the
forefront of their industry – a position secured for far more than the near
future.
Contact Us:
Company
Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Comments
Post a Comment